Surgical Science Sweden AB (publ) (SUS.ST) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. SUS.ST files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 4.37% | 30.00% | Pass |
| Interest-bearing investments | 23.90% | 30.00% | Pass |
| Non-permissible income | 1.80% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.40% | 33.00% | Pass |
| Interest-bearing investments | 13.14% | 33.00% | Pass |
| Non-liquid assets | 83.94% | at least 20.00% | Pass |
| Non-permissible income | 1.80% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.40% | 33.33% | Pass |
| Cash + interest-bearing securities | 13.14% | 33.33% | Pass |
| Accounts receivable | 16.06% | 33.33% | Pass |
| Non-permissible income | 1.80% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.40% | 33.33% | Pass |
| Cash + interest-bearing securities | 13.14% | 33.33% | Pass |
| Accounts receivable | 16.06% | 50.00% | Pass |
| Non-permissible income | 1.80% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.40% | 33.00% | Pass |
| Cash + interest-bearing securities | 13.14% | 33.00% | Pass |
| Accounts receivable | 2.92% | 33.00% | Pass |
| Non-permissible income | 1.80% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.00% | 33.00% | Pass |
| Cash + interest-bearing securities | 10.92% | 49.00% | Pass |
| Accounts receivable | 2.43% | 49.00% | Pass |
| Non-permissible income | 1.80% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 2.00% | 33.33% | Pass |
| Cash + interest-bearing securities | 10.92% | 33.33% | Pass |
| Accounts receivable | 13.35% | 49.00% | Pass |
| Non-permissible income | 1.80% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 66.40 | NEUTRAL |
| Stochastic %K (14) | 43.62 | NEUTRAL |
| CCI (20) | 36.69 | NEUTRAL |
| Williams %R (14) | -56.38 | NEUTRAL |
| MACD (12,26,9) | -0.53 | SELL |
| ROC (10) | -1.46 | SELL |
| Momentum (10) | -0.75 | SELL |
| EMA (10) | 50.82 | SELL |
| SMA (10) | 51.67 | SELL |
| EMA (20) | 48.42 | BUY |
| SMA (20) | 49.12 | BUY |
| EMA (30) | 45.94 | BUY |
| SMA (30) | 44.83 | BUY |
| EMA (50) | 42.50 | BUY |
| SMA (50) | 39.41 | BUY |
| EMA (100) | 39.81 | BUY |
| SMA (100) | 36.47 | BUY |
| EMA (200) | 43.93 | BUY |
| SMA (200) | 34.47 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Health Information Services
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was founded in 1997 and is based in Gothenburg, Sweden.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.